Table 4 Association between symptomatic acute SARS-CoV-2 infection and subsequent development of Long COVID-19 symptoms in the primary care setting
Long COVID-19 symptoms | Symptomatic acute SARS-CoV-2 infection (n = 230) | Non symptomatic acute SARS-CoV-2 infection (n = 399) | p-value |
|---|---|---|---|
At least one symptom | 107 (46.5) | 46 (11.5) | < 0.001 |
Abnormal fatigue | 38 (16.5) | 6 (1.5) | < 0.001 |
Neurological symptoms | 33 (14.4) | 10 (2.5) | < 0.001 |
Respiratory symptoms | 20 (8.7) | 18 (4.5) | 0.038 |
Psychological symptoms | 20 (8.7) | 11 (2.8) | 0.002 |
Muscle and joint pains | 22 (9.6) | 9 (2.3) | < 0.001 |
Loss of taste – smell | 20 (8.7) | 1 (0.25) | < 0.001 |
Gastrointestinal symptoms | 12 (5.2) | 7 (1.8) | 0.026 |
Dermatological disorders | 9 (3.9) | 3 (0.75) | 0.011 |
Palpitations and cardiac disorders | 4 (1.7) | 1 (0.25) | 0.062 |
Other symptoms | 3 (1.3) | 1 (0.25) | 0.141 |